Your browser doesn't support javascript.
loading
Safety and Outcomes of a Plasmid DNA Vaccine Encoding the ERBB2 Intracellular Domain in Patients With Advanced-Stage ERBB2-Positive Breast Cancer: A Phase 1 Nonrandomized Clinical Trial.
Disis, Mary L Nora; Guthrie, Katherine A; Liu, Ying; Coveler, Andrew L; Higgins, Doreen M; Childs, Jennifer S; Dang, Yushe; Salazar, Lupe G.
Afiliación
  • Disis MLN; University of Washington Medicine Cancer Vaccine Institute, University of Washington, Seattle.
  • Guthrie KA; Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, Washington.
  • Liu Y; University of Washington Medicine Cancer Vaccine Institute, University of Washington, Seattle.
  • Coveler AL; University of Washington Medicine Cancer Vaccine Institute, University of Washington, Seattle.
  • Higgins DM; University of Washington Medicine Cancer Vaccine Institute, University of Washington, Seattle.
  • Childs JS; University of Washington Medicine Cancer Vaccine Institute, University of Washington, Seattle.
  • Dang Y; University of Washington Medicine Cancer Vaccine Institute, University of Washington, Seattle.
  • Salazar LG; University of Washington Medicine Cancer Vaccine Institute, University of Washington, Seattle.
JAMA Oncol ; 9(1): 71-78, 2023 01 01.
Article en En | MEDLINE | ID: mdl-36326756
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Vacunas de ADN Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Vacunas de ADN Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Female / Humans / Middle aged Idioma: En Revista: JAMA Oncol Año: 2023 Tipo del documento: Article